Showing results (451-460 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|November 13, 2019
Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation GroupKiyotaka Izumi, Junya Kanda, Momoko Nishikori, et al.
Annals of Hematology|November 29, 2019
A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disordersWittaya Jomoui, Wanicha Tepakhan, Supawadee Yamsri, et al.
Annals of Hematology|December 2, 2019
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemiaTatsuya Konishi, Noriko Doki, Akihito Nagata, et al.
Annals of Hematology|December 22, 2017
CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimensXiao-Ying Qin, Jin Lu, Guo-Xuan Li, et al.
Annals of Hematology|February 6, 2019
Hyperuricemia, urine uric excretion, and associated complications in thalassemia patientsJuthatip Chaloemwong, Adisak Tantiworawit, Thanawat Rattanathammethee, et al.
Annals of Hematology|January 13, 2019
Nilotinib combined with multi-agent chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center prospective study with long-term follow-upBingcheng Liu, Ying Wang, Chunlin Zhou, et al.
Annals of Hematology|December 28, 2019
Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCTGuangqiang Meng, Jingshi Wang, Xinkai Wang, et al.
Annals of Hematology|December 18, 2019
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)Albert Esquirol, Sergi Querol, Irene Garcia-Cadenas, et al.
Annals of Hematology|December 18, 2019
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experienceMurat Özbalak, Ayşe Salihoğlu, Teoman Soysal, et al.
Annals of Hematology|December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplantMassimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
Pageof 667